在脏疾病中释放NFAT通路的治疗潜力
Shruti Shreya1, Neha Dagar1, Anil Bhanudas Gaikwad2
1Department of Pharmacy, Birla Institute of Technology and Science, Pilani Campus, Pilani, Rajasthan, 333031, India.
Naunyn-Schmiedeberg's archives of pharmacology
|March 15, 2025
概括
激活T细胞的核因子 (NFAT) 通过促进细胞死亡和纤维化,在病中发挥关键作用. 降低NFAT的调节显示为减轻脏损伤的治疗策略有希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 激活T细胞的核因子 (NFAT) 是细胞过程中至关重要的转录因子.
- NFAT与脏疾病的发病有关,有助于管状皮细胞的亡.
- 较高的NFAT水平与病进展相关.
研究的目的:
- 审查NFAT在病病原发生中的作用和调节.
- 要突出支持NFAT下调作为治疗策略的临床前证据.
- 为未来对NFAT向治疗的临床研究奠定基础.
主要方法:
- 在病中对NFAT进行临床前研究的综述.
- 在病理生理学中分析NFAT/尿素信号通路.
- 检查针对NFAT的潜在治疗剂.
主要成果:
- 由和氨酸调节的NFAT激活导致核局部化,并促进细胞亡,炎症和纤维化.
- 在临床前模型中,NFAT的降低调节或沉默已被证明可以减轻脏疾病.
- 几种药物,如安纳米德,11R-VIVIT和maxacalcitol正在研究它们对NFAT的调节潜力.
结论:
- NFAT是病病原体的重要贡献者.
- 向NFAT代表了对脏疾病的有希望的治疗途径.
- 需要进一步的临床研究来将这些临床前发现转化为有效的治疗方法.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Nephrons
1.9K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
1.9K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


